Detection of DNA methylation adducts in Hodgkin's disease patients treated with procarbazine

Biomarkers

Volumn 1, Issue 4, 1996, Pages 226-231

  Bianchini, F ^a   Weiderpass, E ^b   Kyrtopoulos, S ^c   Souliotis, V L ^c   Henry Amar, M ^d   Wild, C P ^f   Boffetta, P ^e  

^a CEA GRENOBLE   (France)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c INSTITUTE OF BIOLOGY   (Greece)

^d CENTRE FRANÇOIS BACLESSE   (France)

^e IARC ^*

^f UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Chemotherapy; DNA methylation adducts; Hodgkin's disease; Molecular epidemiology; Procarbazine

Indexed keywords

EID: 0000619740     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.3109/13547509609079362     Document Type: Article

References (30)

1. BIANCHINI, F. AND WILD, C. P. (1994a) 7-Methyldeoxyguanosine as a marker of exposure to environmental methylating agents. Toxicology Letters, 72, 175-184.
2. BIANCHINI, F. AND WILD, C. P. (1994b) Comparison of 7-medG formation in white blood cells, liver and target organs in rats treated with methylating carcinogens. Carcinogenesis 15, 1137-1141.
3. BIANCHINI, F., MONTESANO, R., SHUKER, D. E. G., CUZICK, J. AND WILD, C. P. (1993) Quantification of 7-methyldeoxyguanosine using immunoaffinity purification and HPLC with electrochemical detection. Carcinogenesis, 14, 1677-1682.
4. BOFETTA, P. AND KALDOR, J. M. (1994) Secondary malignancies following cancer chemotherapy. Acta Oncologica, 33, 591-598.
5. CARDE, P. (1990) Chemotherapy of Hodgkin's disease. Nouvelle Revue Français d'Hematologie 32, 169-173.
6. CHAKRAVARTI, D., IBEANU, G. C., TANO, K. AND MITRA, S. (1991) Cloning and expression in Escherichia coli of a human cDNA encoding the DNA repair protein N-methylpurine-DNA glucosylase. Journal of Biological Chemistry, 266, 15710-15715.
7. 6-alkylguanine-DNA alkyltransferase. Science 259, 219-222.
8. 6-alkylguanine-DNA alkyl transferase activity determinations in rat mammary carcinogenesis by procarbazine and N-methylintrosourea. Carcinogenesis, 11, 411-417.
9. FONG, L. Y. Y., BEVILL, R. F., THURMON, J. C. AND MAGEE, P. N. (1992) DNA adduct dosimetry and DNA repair in rats and pigs given repeated doses of procarbazine under conditions of carcinogenicity and human cancer chemotherapy respectively. Carcinogenesis, 13, 2153-2159.
10. JELINEK, J., KLEIBEL, K., DEXTER, T. M. AND MARGISON, G. P. (1988) Transfection of murine multi-potent haemopoietic stem cells with an E. coli DNA alkyltransferase gene confers resistance to the toxic effects of alkylating agents. Carcinogenesis, 9, 81-87.
11. LEE, I. P., AND DIXON, R. L. (1978) Mutagenicity, carcinogenicity and teratogenicity of procarbazine. Mutation Research, 55, 1-14.
12. 6-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine. Cancer Research, 51, 619-623.
13. LEE, S. M., MARGISON, G. P., THATCHER, N., O'CONNOR, P. J. AND COOPER, D. P. (1994) Formation and loss of O-methyldeoxyguanosine in human leukocyte DNA following sequential DTIC and fotemustine chemotherapy. British Journal of Cancer, 69, 53-57.
14. LOEB, L. A., PRESTON, B. D., SNOW, E. T. AND SCHEAPER, R. M. (1985) Apurinic sites as common intermediates in mutagenesis. In Mechanisms of DNA Damage and Repair, M. G. Simic, L. Grossman and A. C. Liton (eds) (Plenum Publishing Corp., New York), pp. 341-347.
15. 6-alkylguanine DNA alkyltransferase in vivo by pretreatment with antineoplastic agents. Biochemical Pharmacology, 38, 929-934.
16. 6-alkylguanine alkyltransferase activity in Chinese hamster V79 cells following selection with chloroethylating agents. Carcinogenesis, 9, 45-49.
17. 32P-postlabelling of 7-methylguanine levels in white blood cell DNA of healthy individuals and cancer patients treated with dacarbazine and procarbazine. Human data and method development for 7-alkylguanines. Carcinogenesis, 12, 1423-1431.
18. 6 position of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents. Cancer Investigation, 2, 223-231.
19. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Research, 50, 6119-6129.
20. PROUGH, R. A. AND TWEEDIE, D. J. (1988) Procarbazine. In Metabolism and Action of Anti-Cancer Drugs, G. Powis and R. A. Prough, eds (Taylor & Francis, New York), pp. 29-47.
21. 6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia. Cancer Research, 48, 3084-3089.
22. SINGER, B. AND GRUNBERGER, D. (1983) In Molecular Biology of Mutagens and Carcinogens (Plenum Press, New York & London).
23. 6-methylguanine. Cancer Research, 49, 6996-7001.
24. 6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair. Cancer Research, 50, 2759-2764.
25. 6-methylguanine in human leukocyte DNA after intravenous exposure to dacarbazine. Carcinogenesis, 12, 285-288.
26. 6-methylguanine in humans and rodents treated with procarbazine. Carcinogenesis, 15, 1675-1680.
27. 6-Methyldeoxyguanosine in oesophageal DNA among individuals at high risk of oesophageal cancer. International Journal of Cancer, 36, 661-665.
28. 6-alkylguanine-DNA alkyltransferase in rat tissues. Carcinogenesis, 15, 1681-1688.
29. 7-methylguanine in DNA of white blood cells from cancer patients treated with dacarbazine. Carcinogenesis, 13, 1257-1259.
30. WIESTLER, O., KLEIHUES, P., RICE, J. AND IVANKOVICH, S. (1984) DNA methylation in maternal, fetal, and neonatal rat tissues following perinatal administration of procarbazine. Journal of Cancer Research and Clinical Oncology, 108, 56-59.